These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 10683558)

  • 1. From hepatitis B to hepatitis A and B prevention: the Puglia (Italy) experience.
    Germinario C; Lopalco PL; Chirona M; Da Villa G
    Vaccine; 2000 Feb; 18 Suppl 1():S83-5. PubMed ID: 10683558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for vaccination against hepatitis A and B in Catalonia (Spain).
    Salleras L; Bruguera M; Buti M; Domíngez A
    Vaccine; 2000 Feb; 18 Suppl 1():S80-2. PubMed ID: 10683557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis A in Puglia (South Italy) after 10 years of universal vaccination: need for strict monitoring and catch-up vaccination.
    Chironna M; Prato R; Sallustio A; Martinelli D; Tafuri S; Quarto M; Germinario C
    BMC Infect Dis; 2012 Oct; 12():271. PubMed ID: 23098290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis A and B in children and adolescents--what can we learn from Puglia (Italy) and Catalonia (Spain)?
    Lopalco PL; Salleras L; Barbuti S; Germinario C; Bruguera M; Buti M; Domínguez A
    Vaccine; 2000 Oct; 19(4-5):470-4. PubMed ID: 11027810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of hepatitis A and B vaccination programme in Germany.
    Szucs T
    Vaccine; 2000 Feb; 18 Suppl 1():S86-9. PubMed ID: 10683559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining hepatitis A and B vaccination in children and adolescents.
    Van Damme P; Van der Wielen M
    Vaccine; 2001 Mar; 19(17-19):2407-12. PubMed ID: 11257370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B school-based vaccination programmes in the USA: a model for hepatitis A and B.
    Koff RS
    Vaccine; 2000 Feb; 18 Suppl 1():S77-9. PubMed ID: 10683556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for acute viral hepatitis--United States, 2006.
    Wasley A; Grytdal S; Gallagher K;
    MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of routine infant and adolescent hepatitis B vaccination in Tuscany, Central Italy.
    Bonanni P; Colombai R; Gasparini R; Lo Nostro A; Tiscione E; Tomei A; Montomoli E; Comodo N
    Pediatr Infect Dis J; 1999 Aug; 18(8):677-82. PubMed ID: 10462335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
    Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
    J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
    Kurugöl Z; Mutlubaş F; Ozacar T
    Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against hepatitis viruses in Poland.
    Slusarczyk J
    Vaccine; 2001 Mar; 19(17-19):2384-8. PubMed ID: 11257365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of hepatitis A and hepatitis B by vaccination].
    Buisson Y; Meyran M
    Ann Gastroenterol Hepatol (Paris); 1995 Oct; 31(5):306-8; discussion 308-9. PubMed ID: 8572566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for the infant and adolescent vaccination programmes in Italy.
    Da Villa G
    Vaccine; 2000 Feb; 18 Suppl 1():S31-4. PubMed ID: 10683541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.
    Keystone JS; Hershey JH
    Int J Infect Dis; 2008 Jan; 12(1):3-11. PubMed ID: 17643334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of hepatitis A by universal vaccination of children and adolescents: an achieved goal or a deferred appointment?
    Martinelli D; Bitetto I; Tafuri S; Lopalco PL; Mininni RM; Prato R
    Vaccine; 2010 Sep; 28(41):6783-8. PubMed ID: 20688041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg.
    Mossong J; Putz L; Patiny S; Schneider F
    Epidemiol Infect; 2006 Aug; 134(4):808-13. PubMed ID: 16436219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on hepatitis B vaccination in Italy 10 years after its implementation.
    Zanetti AR
    Vaccine; 2001 Mar; 19(17-19):2380-3. PubMed ID: 11257364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.